United Kingdom· GB-APID-8579011000001107
Angiox 250mg powder for concentrate for solution for infusion vials
A bivalirudin product containing bivalirudin, registered in United Kingdom by The Medicines Company UK Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bivalirudin is registered in 11 of 19 countries.
Countries holding a registration under ATC B01AE06 (bivalirudin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Bivalirudin · ATC B01AE06
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bivalirudin
- Manufacturer
- The Medicines Company UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- B01AE06
- ATC class
- Bivalirudin
- Defined daily dose
- 0.25 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
148 interactions on record for bivalirudin.
Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bivalirudin · interactions on record
148 records
- 63 severe
- 85 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bivalirudin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAngioxOrifarm Oy
- BelgiumAngiox 250 mgThe Medicines Company
- SpainBIVALIRUDINA ACCORD 250 MG DE POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandBiwalirudyna AccordAccord Healthcare Polska Sp. z o.o.
- SwedenBivalirudin Reig Jofre 250 mg Pulver till koncentrat till injektions-/infusionsvätska, lösningBioglan AB
- United StatesbivalirudinSandoz Inc
- CanadaANGIOMAXSANDOZ CANADA INCORPORATED
- NetherlandsBivalirudine Accord 250 mg poeder voor concentraat voor oplossing voor injectie/infusieAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Bivalirudin Accord
- Belgium · Bivalirudin Accord Healthcare, Bivalirudin Hikma
- Germany · Bivalirudin Accord
- Denmark · Bivalirudin Reig Jofre
- Spain · Bivalirudina Hikma, Bivalirudina Sala
- Finland · Bivalirudin Bioglan
- France · Bivalirudine Accord, Bivalirudine Hikma
- Italy · Bivalirudina Accord, Bivalirudina Hikma
- Netherlands · Bivalirudine Accord, Bivalirudine Hikma
- Poland · Biwalirudyna Accord
- Portugal · Bivalirudina Accord, Bivalirudina Hikma
- Sweden · Bivalirudin Reig Jofre
- Slovenia · Bivalirudin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9ae9f9a-f23b-471a-abb5-5f5c015c3605 GET /v1/drugs/b9ae9f9a-f23b-471a-abb5-5f5c015c3605?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "8579011000001107",
"desc": "Angiox 250mg powder for concentrate for solution for infusion vials (The Medicines Company UK Ltd)",
"form": "Powder for solution for infusion",
"vpid": "8578811000001108",
"source": "dmd",
"vtm_id": "774885001",
"strength": "250 mg",
"substance": "Bivalirudin",
"ingredient": "Bivalirudin",
"supplier_code": "14780411000001100"
}See everything about bivalirudin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.